| 000 | 00954 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517223256.0 | ||
| 264 | 0 | _c20190711 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1520-6777 | ||
| 024 | 7 |
_a10.1002/nau.23734 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGibson, William | |
| 245 | 0 | 0 |
_aTrends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada. _h[electronic resource] |
| 260 |
_bNeurourology and urodynamics _c11 2018 |
||
| 300 |
_a2977-2978 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAcetanilides |
| 650 | 0 | 4 | _aBenzhydryl Compounds |
| 650 | 0 | 4 | _aCanada |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aThiazoles |
| 650 | 0 | 4 | _aUrinary Bladder, Overactive |
| 700 | 1 | _aWagg, Adrian | |
| 773 | 0 |
_tNeurourology and urodynamics _gvol. 37 _gno. 8 _gp. 2977-2978 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/nau.23734 _zAvailable from publisher's website |
| 999 |
_c28544638 _d28544638 |
||